Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 91Myelodysplastic Syndromes 26Leukemia, Myelomonocytic, Chronic 12Myeloproliferative Disorders 8Leukemia 6Hematologic Neoplasms 5Recurrence 4Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Hematologic Diseases 3Anemia, Refractory, with Excess of Blasts 3Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Immunoblastic Lymphadenopathy 2Thrombocytosis 1Thrombocythemia, Essential 1Sarcoma, Myeloid 1Pathologic Complete Response 1Neurofibromatosis 1 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 45fludarabine 32Methotrexate 24blinatumomab 20Vincristine 19Dexamethasone 19fludarabine phosphate 18Specimen Handling 17Cytarabine 17Whole-Body Irradiation 14Melphalan 13Tacrolimus 12Calcium Dobesilate 12Biopsy 12Mercaptopurine 11Busulfan 11merphos 10Peripheral Blood Stem Cell Transplantation 10Mycophenolic Acid 10Thiotepa 9Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 9Doxorubicin 9venetoclax 8ponatinib 8dexamethasone acetate 8dexamethasone 21-phosphate 8Prednisone 8Mesna 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Azacitidine × 90 days × Clear all
NCT04988555 2026-03-24

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Sumitomo Pharma America, Inc.

Phase 1/2 Recruiting
606 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡